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Abstract 42 
Gastrointestinal (GI) disease is a common clinical complaint in small animal patients; 43 
computed tomography (CT) examinations enable a global overview of the GI tract and 44 
associated structures. Previously, the GI wall has been reportedly identified from serosa to 45 
mucosa in 77% of standard postcontrast CT studies and wall layers seen in ultrasound have 46 
not been distinguished. Inconsistent strong contrast enhancement of the inner layer of the 47 
GI mucosal surface was noted on dual phase CT studies acquired in our institution, which 48 
increased the visibility of the GI tract and disease processes. The aim of this retrospective, 49 
observational, cross-sectional study was to determine the optimal portal vein attenuation 50 
for maximizing GI wall conspicuity using dual phase contrast-enhanced CT. Patients with 51 
abdominal CT for a non-GI related disease were included. In a pilot study, 175 GI segments 52 
from 35 CT studies were graded for presence of mucosal surface enhancement (MSE). The 53 
strongest mucosal surface enhancement grade correlated with portal vein attenuation of 54 
43–150 HU; this value was used as inclusion criterion in the main study. A total of 441 GI 55 
segments were evaluated in 42 CT studies postcontrast for GI wall conspicuity. The GI 56 
wall was conspicuous in 56.7% precontrast, 84.5% at 30s, and 77.3% late postcontrast; 57 
4.7% of segments were removed due to motion blur. At 30 s distinct mucosal surface 58 
enhancement was seen in the small intestine and gastric mucosal surface enhancement was 59 
poor. Findings supported the use of dual phase contrast-enhanced CT for improving 60 
conspicuity of the GI wall. © 2016 American College of Veterinary Radiology. 61 
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Introduction 74 
Gastrointestinal disease can represent a diagnostic challenge in small animals using 75 
noninvasive techniques. First-line modalities used in patients with gastrointestinal disease 76 
commonly include conventional radiography, contrast radiography, or ultrasound (US). 77 
The diagnostic value of these imaging studies is influenced by a number of factors.1 In 78 
human medicine, computed tomography is broadly utilized for diagnosis and staging of 79 
gastrointestinal neoplasia, clinical workup of acute abdominal pain, detection of 80 
gastrointestinal bleeding as well as inflammatory or vascular disorders and assessment of 81 
postoperative complications of gastrointestinal surgery.2–5 The utility of computed 82 
tomography (CT) for diagnostic workup of abdominal disease is established in the 83 
veterinary literature, however a limited focus has been placed on the use of computed 84 
tomography (CT) specifically for evaluation of the gastrointestinal tract.6,7 Only one prior 85 
study describes standard pre- and postcontrast CT to evaluate the gastrointestinal tract in 86 
dogs. In that study, 62.8% of gastrointestinal segments and 77.7% of gastrointestinal walls 87 
were seen.8 Wall layering on the postcontrast examination was only identified in 21.8% of 88 
gastrointestinal segments. Another study focused on the evaluation of the gastric wall using 89 
helical hydro CT.9 Dual phase contrast-enhanced CT examinations have been routinely 90 
acquired at our institution for other clinical purposes using non individualized bolus 91 
injection timing at 30 s and 60–180 s (late postcontrast examination) after initiating the 92 
intravenous iodinated contrast bolus. Pronounced enhancement of the inner layer of the 93 
gastrointestinal tract, particularly the stomach and small intestine, was noted intermittently 94 
on the studies acquired in the 30 s and late postcontrast examinations. This enhancement 95 
subjectively aided in the depiction of the gastrointestinal wall compared to regular 96 
postcontrast studies acquired at approximately 60 s postcontrast injection. The sonographic 97 
appearance of normal gastrointestinal wall layering is well described in the literature. A 98 
similar description of normal gastrointestinal wall layering in post- contrast CT 99 
examinations has not been described in veterinary patients.10 100 
The overall goal of this study was therefore to evaluate dual phase CT as a possible 101 
future method for gastrointestinal disease evaluation in dogs. The first specific aim 102 
was to determine when this contrast enhancement pattern would appear in relation 103 
to abdominal vascular enhancement. The second specific aim was to determine if 104 
dual phase contrast CT would allow for improvement of intestinal wall conspicuity 105 
compared to prior veterinary studies, by enhancing the distinction between lumen 106 
and mucosal surface using a dual phase examination as compared to standard 107 
postcontrast CT.8 Our hypotheses were twofold: (1) distinct enhancement of the 108 
inner layer of the gastrointestinal segments would occur early in postcontrast period; 109 
and (2) contrast enhancement of the inner layer of the gastrointestinal wall would 110 
increase detection of gastrointestinal segments as compared to standard postcontrast 111 
CT. 112 
Material and Methods 113 
Subject Selection 114 
The design of this study was observational, cross- sectional, and retrospective. 115 
Computer records at the Royal Veterinary College were searched for dogs having 116 
had dual phase contrast CT examination of the abdomen between January 2013 and 117 
December 2014. Prior to January 2013 and after December 2014, two postcontrast 118 
CT examinations were not routinely acquired. Dual phase contrast CT was defined 119 
as two postcontrast acquisitions. These acquisitions were generically timed at 30 s 120 
and at least 60 s after beginning of contrast administration. The initial exclusion 121 
criteria for the study were: recent history (previous 6 months) of gastrointestinal 122 
illness, a final diagnosis of gastrointestinal related disease, vascular anomalies (e.g. 123 
caudal vena cava duplication, portosystemic shunt), venous hind limb injection, or 124 
hand injection. Patients where CT studies were acquired after magnetic resonance 125 
imaging (MRI) examination were also excluded as the presence of residual 126 
gadolinium may have affected the enhancement patterns of the intestine. Patient 127 
selection was performed by the first author (second-year resident). The breed, age, 128 
and weight of each dog meeting the inclusion criteria were recorded. 129 
As part of the inclusion criteria, all patients were scanned in sternal recumbency 130 
from cranial to caudal using 16 multidetector row computed tomography unit 131 
(MDCT) (Mx8000 IDT, Philips, Best, The Netherlands). The majority of patients 132 
had both thoracic and abdominal CT. The following helical CT protocol was used: 133 
16 × 1.5 mm collimation, 1.5 cm slice overlap, tube rotation time of 0.5 s, 150 mA 134 
(nominal), 120 kVp, 3 mm slice thickness, and display field of view tailored to 135 
patient size. 136 
Images were generated using a soft tissue reconstruction algorithm. Intravenous 137 
iodinated contrast medium (Omnipaque, iohexol, 300 mg I/ml, GE Healthcare AS, 138 
Nycoveie 1–2, NO-0401 Oslo, Norway; 2 ml/kg body weight) was administered 139 
using a power injector (Stellant, Medrad Inc., PA), with pressure limit set at 150 psi. 140 
Postcontrast images were acquired at 30 s from the start of contrast administration. 141 
A second postcontrast scan was performed late postcontrast with variability in the 142 
timing of the late postcontrast study (range of 60–180 s). 143 
A single review of retrieved images was performed by the primary author (E.F.) 144 
followed by consensus review with the last author (R.D.). For the image review 145 
studies were reviewed in three batches; precontrast, 30 s postcontrast, and late 146 
postcontrast. The patient’s identification number was used to identify studies; 147 
patient name and age were removed from DICOM images prior to review. Both 148 
readers were unaware of patient breed, age, weight, and final diagnosis during the 149 
evaluation of the CT studies. 150 
Determining the Optimal Contrast Enhancement Time 151 
A pilot study was conducted to select for studies with optimal contrast enhancement 152 
of the inner layer of the gastrointestinal tract (denoted as mucosal surface 153 
enhancement (MSE) for the purposes of this study) in the 30 s postcontrast 154 
examination within a narrow range of vessel attenuation using a representative 155 
sample of the population that met the inclusion criteria. The pilot study comprised 156 
three steps: (1) grade mucosal surface enhancement of five gastrointestinal 157 
segments, (2) record abdominal vessel attenuation at four sites, (3) correlate grade 158 
of mucosal surface enhancement with vessel attenuation. To grade the mucosal 159 
surface enhancement, five representative gastrointestinal segments were selected 160 
from each of these CT studies: gastric body, descending duodenum, jejunum, ileum, 161 
and descending colon. A subjective three-tiered grading system was used (Fig. 1): 162 
good (1, distinct mucosal surface enhancement), moderate (2, faint mucosal surface 163 
enhancement), and poor (3, no difference between the inner surface and remainder 164 
of the gastrointestinal wall). 165 
Abdominal vascular attenuation was recorded at four sites in each of these CT 166 
examination: portal vein and aorta at the level of the porta hepatis; aorta and caudal 167 
vena cava immediately cranial to the aortic bifurcation. This was achieved by 168 
placing a region of interest that covered >80% of the vascular lumen and recording 169 
the mean HU measured (Fig. 2). The ranges of attenuation values for the aortic, 170 
CVC, and portal vein measurements were recorded (Table 1). Abdominal vascular 171 
attenuation was evaluated for variability in contrast enhancement, to select the 172 
vessel with the narrowest range of Hounsfield units. Shapiro- Wilk test was 173 
performed to test for normalcy of distribution of vascular enhancement compared 174 
to mucosal surface enhancement recorded. The mean or median value and range of 175 
the portal vein values for these studies were calculated. 176 
 177 
FIG. 1. Grades of mucosal surface enhancement (MSE); 1 = Good (A), 2 = moderate (B) and 3 = poor (C) as used for the 178 
pilot study in the first 35 dogs to meet the inclusion criteria. 179 
 180 
FIG. 2. (A) Cranial aorta and portal vein. (B) Caudal aorta and CVC measurements of vessel attenuation. 181 
 182 
TABLE 1. Range of Vessel Attenuation Values in the Pilot Study; Using 30 s Postcontrast Scans of the First 35 183 
Examinations that Met the Initial Inclusion Criteria 184 
 Range (HU) 
Cranial Aorta 206-720 
Caudal Aorta 210-654 
Portal Vein 39-150 
* CVC attenuation values were censored from further analysis 185 
 186 
Determining Whether Dual Phase Contrast CT Improved Gastrointestinal Wall 187 
Conspicuity 188 
An additional inclusion criterion of 43–150 HU portal vein attenuation in the 30 s 189 
postcontrast examinations was introduced for the main study to standardize portal 190 
vascular enhancement between studies in lieu of the absence of specific bolus 191 
timing. Analogous to the prior study, the gastrointestinal tract was divided into 192 
eleven segments: gastric body, pyloric antrum, pylorus, descending duodenum, 193 
transverse duodenum, jejunum, ileum, ileocolic junction, transverse colon, 194 
descending colon and rectum The gastrointestinal wall conspicuity of each segment 195 
was recorded for pre and both, the 30 s and late postcontrast studies. Gastrointestinal 196 
wall conspicuity was defined by the ability to identify the gastrointestinal segment 197 
wall from serosa to mucosa and to follow that section of gastrointestinal tract for 198 
greater than 75% of the entire length of the segment. Gastrointestinal wall 199 
conspicuity was recorded as seen (yes) or not seen (no); the reason for inability to 200 
detect the segment was recorded. In the case of ileocolic junction, the wall of the 201 
ileocolic orifice was evaluated. Each gastrointestinal segment was evaluated 202 
precontrast, at 30 s and late postcontrast. If motion caused blurring of a 203 
gastrointestinal segment that segment was excluded from evaluation in the pre, 30 204 
s and late postcontrast examination. Statistical comparisons for gastrointestinal wall 205 
conspicuity were per- formed by the first author (E.F.) using commercial software 206 
(SPSS version 19, SPSS Inc., Chicago, IL). 207 
Results 208 
The records of 1,396 patients with abdominal CT examinations were reviewed. 209 
Ninety-three CT examinations from 46 dogs met the initial inclusion criteria. The 210 
first 35 dogs from this population were selected for inclusion in the pilot study (Fig. 211 
3). In patients with multiple studies, the initial CT examination was selected for 212 
evaluation. 213 
 214 
FIG. 3. Flow chart illustrating criteria used for patient selection. 215 
In the pilot study, the intensity of mucosal surface enhancement differed markedly 216 
between different areas of the gastrointestinal tract in 30 s postcontrast studies. A 217 
good mucosal surface enhancement (grade 1) was frequently identified in the small 218 
intestine (duodenum, jejunum, and ileum) and large intestine at 30 s in the pilot 219 
study. Mucosal surface enhancement of the gastric body was found to be poor (grade 220 
3) at 30 s postcontrast. During evaluation of vascular contrast enhancement in the 221 
pilot study, a number of cases showed the caudal vena cava dorsoventrally flattened 222 
due to inappropriate placement of positioning aids and/or a markedly distended 223 
urinary bladder. Thus, the vessel lumen could not be reliably identified, making 224 
measurements of vessel attenuation unreliable. Therefore, the caudal vena cava 225 
attenuation values were censored from further analysis. 226 
Intrapatient variation in aortic attenuation between the cranial and caudal sites was 227 
considered low (4–136 HU). Therefore, an average aortic attenuation of the cranial 228 
and caudal sites was calculated and used for further interpatient comparisons. There 229 
was a large range in the interpatient average aortic attenuation (218.5–603.5 HU). 230 
When comparing interpatient aortic and portal vein values, less variation was noted 231 
in the portal vein attenuation measurements (portal vein attenuation range 39–150 232 
HU). Thus portal vein attenuation was selected for correlation with grade 1 mucosal 233 
surface enhancement. 234 
Tests for normality (Shapiro-Wilk) indicated the portal vein attenuation values for 235 
grade 1 mucosal surface enhancement of duodenum, jejunum, and ileum were 236 
normally distributed (P-value > 0.05). The portal vein attenuation values for grade 237 
1 colonic mucosal surface enhancement were not normally distributed; thus a 238 
median portal vein attenuation value was calculated for the colon. 239 
Mean and median portal vein attenuation values for the grade 1 mucosal surface 240 
enhancement of the duodenum, jejunum, ileum, and descending colon were 94, 87, 241 
81, and 64 HU, respectively (Table 2); hence the range of 43–150 HU portal vein 242 
attenuation in the 30 s postcontrast examinations was used as an additional criterion 243 
for patient selection. This criterion standardized portal vascular enhancement 244 
between studies in the absence of patient-specific bolus timing based on grade 1 245 
mucosal surface enhancement of the duodenum, jejunum, ileum, and colon. 246 
TABLE 2. Portal Vein Value for Grade 1 Enhancement of Gastrointestinal Segments of the Thirty-247 
Five Studies of the 30 s Postcontrast Scan in the Pilot Study  248 
 Mean PV* 
attenuation 
(HU) 
SD PV 
attenuation 
(HU) 
Range PV 
attenuation 
(HU) 
Gastric body N/A N/A  
Duodenum 94 31 45-150 
Jejunum 87 36 43-150 
Ileum 81 27 43-150 
Colon 64† N/A 45-150 
*Portal vein, †median value  249 
 250 
The introduction of the additional selection criterion excluded 54/96 CT 251 
examinations. The remaining 42 CT examinations from 39 dogs were finally 252 
included in the main study. 253 
The 39 dogs included in the main study had a me- dian age of 10 years (range 2.5–254 
14 years). Of the dogs included there were 19 neutered males, 14 neutered females, 255 
and six entire male dogs. The study population consisted of 12 crossbreeds, five 256 
Labradors, three English Springer Spaniels, two Dobermans, and one each of 16 257 
other breeds (Basset Hound, Beagle, Boxer, Cavalier King Charles Spaniel, Cocker 258 
Spaniel, Chow Chow, Golden Retriever, Hungarian Vizsla, Irish setter, Irish Terrier, 259 
Jack Russell Terrier, Lurcher, Poodle, Rottweiler, Tibetan Terrier, West Highland 260 
White Terrier). The median weight of the dogs was 24 kg (range 10–47 kg). 261 
A total of 441 gastrointestinal segments in 42 CT examinations (one patient had 262 
four CT studies) were evaluated for wall conspicuity in the main study. Twenty-one 263 
segments (4.7%) were excluded due to motion blur. A summary of the results is 264 
included in Table 3. 265 
TABLE 3. Results of Main Study: Number (%) of Gastrointestinal Segments Identified in Each 266 
Examination (n = 39 dogs)  267 
 
Pre-
contrast 
30s post 
contrast 
Late post 
contrast 
Segments 
excluded 
Gastric body 9(22.5%) 17(42%) 24(60%) 2(5%) 
Pyloric antrum 10(24.3%) 22(53.6%) 31(75.6%) 1(2.3%) 
Pylorus 17(42.5%) 18(45%) 28(70%) 2(5%) 
D. Duodenum* 28(66.6%) 42(100%) 36(85.7%) 0(0%) 
T. Duodenum† 22(55%) 40(100%) 32(80%) 2(5%) 
Jejunum 6(16.2%) 37(100%) 9(24.2%) 5(12.5%) 
Ileum 19(52.7%) 34(94.4%) 28(77.75) 6(16.6%) 
ICJ‡ 33(82.5%) 40(100%) 38(95%) 2(5%) 
T. Colon§ 37(92.5%) 40(97.5%) 38(92.6%) 1(2.3%) 
D. Colon|| 39(92.8%) 42(100%) 41(97.6%) 0(0%) 
Rectum 29(69%) 41(97.6%) 39(92.8%) 0(0%) 
* Descending duodenum, † Transverse duodenum, ‡ Ileocolic junction, 268 
§Transverse colon, ||Descending colon 269 
 270 
Gastric Wall Conspicuity 271 
Two of the gastric body segments were removed from calculations due to motion 272 
blur. The remaining 40 gastric body segments were included in the evaluation. The 273 
highest number of clearly defined gastric body segments (24/40, 60%) was seen in 274 
the late examinations (Fig. 4). In 17 of these late postcontrast examinations the 275 
mucosal surface enhancement had intensified since the 30 s scan was acquired. The 276 
gastric lumen was collapsed in all examinations where the gastric body wall could 277 
not be distinguished. In precontrast examinations the gastric body wall was only 278 
identified if the lumen was distended with fluid and/or gas. At 30 s the gastric wall 279 
was not defined in 22/40 (55%) segments due to poor mucosal surface enhancement 280 
with or without a collapsed lumen. In the late postcontrast study, collapse of the 281 
lumen was a common cause for inability to distinguish the gastric wall and was seen 282 
in 40% (16/40) of the examinations. 283 
Pyloric Antrum Wall Conspicuity 284 
The pyloric antral wall was clearly identified most frequently in late postcontrast 285 
examinations (Fig. 5). One segment was removed from the calculations due to 286 
motion. The pyloric antral wall was clearly visible in 10/41 (24.3%) examinations 287 
precontrast, 22/41 (53.6%) at 30 s and 31/41(75.6%) late postcontrast. Precontrast 288 
the pyloric antral wall was only clearly delineated in the presence of luminal gas 289 
and/or fluid. At 30 s postcontrast poor mucosal surface enhancement alone inhibited 290 
delineation of the pyloric antral wall in 12/41 (29.2%) segments. In combination 291 
with poor mucosal surface enhancement, luminal collapse prevented distinguishing 292 
the wall from serosa to mucosa in a further six pyloric antral segments. 293 
Pylorus Wall Conspicuity 294 
Two pyloric segments were removed from calculations due to motion. In the 295 
remaining 40 examinations the pyloric sphincter wall was clearly defined in almost 296 
equal numbers precontrast (17/40, 42.5%) and at 30 s postcontrast (18/40, 45%). In 297 
the late postcontrast examination this figure in- creased to 28/40 (70%) segments 298 
(Fig. 4). In the absence of intraluminal gas or fluid or in the presence of ingesta, the 299 
pyloric lumen/mucosal interface could not be defined in precontrast images. At 30 300 
s postcontrast, mucosal surface enhancement allowed identification of the pyloric 301 
wall in three additional segments. Poor mucosal surface enhancement at 30 s in the 302 
remaining 20/40 (50%) cases prevented delineation of the pyloric wall. In the late 303 
postcontrast examination the pyloric wall of 12/40 (30%) cases could not be 304 
defined; the pyloric lumen was collapsed in all of these 12 cases. 305 
306 
FIG. 4. Gastric body, pyloric antrum and pylorus (white arrow) precontrast (A), at 30 s (B) and late (C) postcontrast in 307 
the main study population. Contrast enhancement of the mucosal surface of the gastric body and pyloric antrum is poor 308 
at 30 s. Enhancement of the gastric body mucosal surface (white arrowheads) improves in the late postcontrast 309 
examination. AO, aorta; PV, portal vein. 310 
 311 
FIG. 5. Close-up images of the pyloric antrum at 30 s (A) and late (B) postcontrast in the main study population. Mucosal 312 
enhancement of the gastric wall (black arrows) and pyloric antrum (white arrow) are seen late postcontrast. 313 
 314 
Descending and Transverse Duodenum Wall Conspicuity 315 
In the 42 examinations the descending duodenal wall was delineated in 28/42 316 
(66.6%) precontrast, 42/42 (100%) at 30 s and 36/42 (85.7%) late postcontrast. 317 
Two transverse duodenal segments were removed due to motion. Of the remaining 318 
40 examinations the transverse duodenal wall was clearly defined in 22/40 (55%) 319 
precontrast, 40/40 (100%) at 30 s and 32/40 (80%) late post- contrast. Precontrast, 320 
14/42 (33.3%) descending duodenal wall segments and 8/40 (20%) transverse 321 
duodenal wall segments were not identified. In all descending and transverse 322 
duodenal segments not identified, the lumen was collapsed devoid of either 323 
intraluminal gas or fluid. 324 
In the late postcontrast images, 6/42(14%) descending duodenum and 8/40(20%) 325 
transverse duodenum wall segments were not defined. The absence of a fluid/gas 326 
filled lumen prevented differentiation of the mucosal surface of opposite intestinal 327 
walls. The mucosal surface enhancement identified in these cases at 30 s was no 328 
longer present. 329 
Jejunum Wall Conspicuity 330 
Five jejunal segments were removed from calculations due to motion blur. In the 331 
remaining 37 examinations, the jejunal wall was clearly delineated in 6/37(16.2%) 332 
precontrast, 37/37 (100%) at 30 s and 9/37 (24.3%) in the late postcontrast 333 
examination. Similar to the duodenum, there was poor definition of jejunal wall 334 
segments in precontrast images when the intestinal lumen was collapsed. In the late 335 
postcontrast examination, 28/37 (75.6%) jejunal wall segments were poorly defined. 336 
This was due to a combination of luminal collapse and the absence of the mucosal 337 
surface enhancement seen at 30 s. 338 
The typical pattern of wall enhancement identified in duodenum and jejunum was 339 
initial enhancement of the luminal surface of the gastrointestinal wall. This was 340 
followed by progressive enhancement of the wall from the luminal to serosal 341 
surface. In the late postcontrast examination, the mucosal surface was 342 
indistinguishable from the remainder of the gastrointestinal wall due to the absence 343 
of sufficient mucosal surface enhancement. Finally, there was washout of contrast 344 
on the luminal surface and prolonged homogeneous enhancement of the outer 345 
gastrointestinal wall (Fig. 6). 346 
347 
FIG. 6. Images of a jejunal segment precontrast (A), at 30 s (B) and late (C) postcontrast in the main study population. 348 
Note the intense enhancement of the mucosal surface at 30 s (white arrow heads). Late postcontrast, there is washout of 349 
contrast from the luminal surface (single white arrow) and enhancement is seen more in the depth of the wall. 350 
 351 
Ileal Wall Conspicuity 352 
Of all segments evaluated, the ileum was most frequently affected by motion blur; 353 
6/42(14%) cases were removed from calculations. The ileal wall was clearly defined 354 
pre- contrast images in 19/36 (52.5%) segments, 34/36 (94.4%) at 30 s and 28/36 355 
(77.7%) late postcontrast (Fig. 7). In pre- contrast images, the ileal wall not 356 
identified in 17/36 (47%) cases due to luminal collapse. Poor mucosal surface 357 
enhancement in 2/36 (5.5%) segments prevented delineation of the ileal wall at 30 358 
s. The wall of the ileum could not be defined in 8/36 (22.2%) segments due to a 359 
combination of poor mucosal surface enhancement and luminal collapse in the late 360 
postcontrast examination. 361 
Ileocolic Junction Wall Conspicuity 362 
Two ileocolic junction segments were removed from calculations due to motion 363 
blur. In the remaining 40 segments the ileocolic junction wall was conspicuous from 364 
mucosa to serosa at similar frequency in pre- and postcontrast ex- aminations: 365 
precontrast 33/40, 40/40 at 30 s and 38/40 late postcontrast (Fig. 7). Similar to the 366 
ileum, the ileocolic junction wall could not be distinguished from the oppos- ing 367 
wall if the lumen did not contain either gas or feces in precontrast images. In the 368 
late postcontrast examination, in 2/40 cases mucosal surface enhancement was poor 369 
and therefore distinguishing the lumen/mucosa interface was not possible. 370 
 371 
FIG. 7. Transverse image of the ileum at 30 s postcontrast (A) and a dorsal reconstructed image of the ileocolic junction 372 
(B) in the main study population. The ileal mucosal surface enhancement has a characteristic appearance in a transverse 373 
section. Ileum (white arrowheads), ileocolic junction (single white arrow), caecum (∗ ), ascending colon (AC), aorta 374 
(AO), right kidney (RK), and left kidney (LK). 375 
Transverse and Descending Colon Wall Conspicuity 376 
One transverse colon segment was removed due to motion blur. In the remaining 41 377 
examinations, the transverse colon wall was clearly defined in 37/41 (92.5%) 378 
precontrast images, 40/41 (97.5%) at 30 s and 38/41 (92.6%) in the late postcontrast 379 
examination. The descending colon wall was clearly defined in 39/42 (92.8%) 380 
precontrast images, 42/42 (100%) at 30 s and 41/42 (97.6%) late postcontrast. In the 381 
majority of colon segments, the lumen was either distended with gas or 382 
hyperattenuating feces, both of which provided excellent contrast with the mucosal 383 
surface of the colonic wall. In 2/41 transverse colon and 2/42 descending colon 384 
segments where the wall was not visible precontrast the lumen was collapsed. At 30 385 
s, mucosal surface enhancement of these four segments enabled identification of the 386 
colonic wall (Fig. 8). In the late postcontrast study, three transverse and one 387 
descending colon wall segment were not identified due to poor mucosal surface 388 
enhancement in the presence of a collapsed lumen. 389 
390 
FIG. 8. Transverse images of the descending colon with a collapsed lumen precontrast (A), at 30 s (B), and late (C) 391 
postcontrast in the main study population. In precontrast images the opposing luminal surfaces are indistinguishable. 392 
Postcontrast, there is enhancement of the luminal surface that is subjectively better at 30 s. Urinary bladder (BL). 393 
Rectum Wall Conspicuity 394 
In the 42 examinations, the rectal wall was conspicuous in 29/42 (69%) precontrast, 395 
41/42 (97.6%) at 30 s and 39/42 (92.8%) in the late postcontrast examination. 396 
Precontrast luminal collapse or presence of isoattenuating feces with a similar 397 
attenuation to rectal wall prevented delineation of the luminal/mucosal interface 398 
(Fig. 9). Poor mucosal surface enhancement was identified in 1/42 cases at 30 s and 399 
3/42 in the late examination in which the luminal/mucosal interface could not be 400 
defined. 401 
 402 
FIG. 9. Transverse images of the rectum within the pelvic canal precontrast(A), at 30 s (B), and late (C) postcontrast in 403 
the main study population. In precontrast images the rectal wall is indistinguishable from the luminal contents (A). At 30 404 
s postcontrast, there is intense enhancement of mucosal surface (white arrowheads). This enhancement persists in the late 405 
postcontrast examination. Note enhancement of the mucosal surface of the urethra in the late examination (single black 406 
arrow) 407 
 408 
In summary, the wall conspicuity of the eleven gastrointestinal wall segments was 409 
56.7% precontrast, 84.5% at 30 s and 77.3% in the late postcontrast examinations. 410 
Discussion 411 
The findings of this study have partially supported the first part of our hypothesis; 412 
that distinct mucosal surface enhancement occurs in early (30 s) postcontrast 413 
examinations for the majority of the evaluated gastrointestinal segments. In the pilot 414 
study mucosal surface enhancement occurred at mean portal vein attenuation values 415 
of 94, 87, and 81 HU for the duodenum, jejunum, and ileum, respectively. The large 416 
intestinal mucosal surface enhancement was identified at a median portal vein 417 
attenuation value of 64.5 HU. In contrast, there was poor mucosal surface 418 
enhancement of the gastric body in the 30 s examination. This was an unexpected 419 
finding. The variation of mucosal surface enhancement between different 420 
gastrointestinal segments, i.e., small intestine vs. gastric body and pyloric antrum 421 
was possibly associated with variations in arterial blood supply. The cranial 422 
mesenteric artery in the dog is the largest visceral branch of the abdominal aorta 423 
measuring up to 5 mm in diameter.11 The vascular supply to the duodenum, jejunum, 424 
ileum, and colon is via the cranial mesenteric artery. Branches of the coeliac artery 425 
supply the gastric wall, liver, spleen, and pancreas. An experimental study by 426 
Delorme et al.12 demonstrated that in 8/13 dogs, 50 to 70% of the circulating 427 
splanchnic blood volume was within the intestine area. A combination of a larger 428 
arterial supply and fewer large organs (liver, spleen, and pancreas) to supply may 429 
ac- count for the early marked mucosal surface enhancement noted in the 30 s 430 
examinations. Depending on the timing of a standard postcontrast examination, 431 
mucosal surface enhancement may be missed. Therefore, to evaluate mucosal 432 
surface enhancement of the small and large intestine an early postcontrast phase is 433 
recommended, authors recommending aiming for a portal vein enhancement at or 434 
above 43 HU. 435 
Gastrointestinal wall conspicuity increased with the use of dual phase contrast-436 
enhanced CT compared to the prior research using standard postcontrast 437 
examination only,8 thus supporting the second part of our hypothesis. In pre- 438 
contrast images, the conspicuity of the gastrointestinal segments was consistently 439 
dependent on dilation of lumen with either gas or fluid, as previously described.8 440 
Collapse of the gastrointestinal lumen made opposing mucosal surfaces in- 441 
distinguishable from each other in 40.9% of the precontrast gastrointestinal 442 
segments analyzed. 443 
In a previous study evaluating standard postcontrast CT, 77.7% of gastrointestinal 444 
wall segments were identified.8 By utilizing the 30 s postcontrast examinations the 445 
rate of gastrointestinal wall detection was increased to 84.5% in the current study. 446 
This was especially true for small intestine (duodenum and jejunum) where all 447 
segments were clearly defined at 30 s (Fig. 6). Addition of the late postcontrast 448 
examinations had a positive impact on the number of gastric body and pyloric antral 449 
wall segments delineated (Fig. 4 and 5). Pronounced mucosal surface enhancement 450 
of the gastric wall was noted in an additional third of cases in the late postcontrast 451 
examination. Similarly, the pyloric sphincter wall was identified in more cases in 452 
the late postcontrast examination than either precontrast or at 30 s postcontrast. The 453 
lack of luminal distension was often the reason for lack of pyloric wall conspicuity. 454 
The ileocolic junction and colonic wall segments were routinely well defined in 455 
precontrast images with gas and/or feces distending the colonic lumen in most cases. 456 
On rare occasions, the colonic lumen was empty and collapsed. In these cases, 457 
mucosal surface enhancement de- fined the luminal surface of the ileal and colonic 458 
walls (Fig. 8). Finally, the rectal wall was conspicuous in over two-thirds of cases 459 
precontrast due to the presence of in- traluminal gas or hyperattenuating feces. In 460 
the absence of rectal lumen dilatation, mucosal surface enhancement in- creased the 461 
number of rectal wall segments seen at 30 s and late postcontrast. As illustrated in 462 
Fig. 9, the intensity of mucosal surface enhancement is subjectively greater at 30 s 463 
compared to the late postcontrast examination. 464 
The unique enhancement pattern of the small intestinal wall was an unexpected 465 
finding. As described above, initially there is intense mucosal surface enhancement. 466 
This enhancement can be attributed to extensive arterial vascular supply to the 467 
intestinal mucosa. As time passes there is progressive enhancement of the remainder 468 
of the intestinal wall with concurrent washout of the contrast from the mucosal 469 
margin. The marked arterial enhancement and lack of accumulation of contrast 470 
within the mucosa is attributable to the microvascular anatomy of intestinal mucosa. 471 
In dogs (and cats) the mucosal surface consists of multiple finger-like villi that 472 
project into the intestinal lumen. A single arteriolar loop projects into each 473 
individual villus. This capillary connects to a submucosal venule.13 Thus a lack of 474 
mucosal veins/venules and the unidirectional flow of blood through the villus 475 
capillary account for enhancement and early washout of contrast from the mucosal 476 
margin. 477 
Dual phase contrast-enhanced CT has been used in people since 1980’s to 478 
investigate gastrointestinal disease. Many advances have been made in the use of 479 
CT for diagnosing, monitoring, and prognosticating neoplastic and inflammatory 480 
conditions such as Crohn’s disease in humans.14,15 In people, abnormal patterns of 481 
wall and mucosal enhancement have been correlated with different inflammatory 482 
dis- ease processes.16 Characteristic intestinal wall changes, particularly of the 483 
ileum, are visible in patients with chronic inflammatory diseases such as Crohn’s 484 
disease.17 485 
Currently, ultrasonography is the imaging modality of choice for investigating 486 
diseases of the gastrointestinal tract in veterinary patients. There are many extrinsic 487 
and intrinsic factors that can negatively impact on the quality of the ultrasound 488 
images acquired. These include, but are not limited to the body habitus of the 489 
patient, intraluminal gas, the quality of the ultrasound equipment used, and the 490 
experience of the operator performing the examination.1,18 In larger patients, 491 
ultrasound may not be appropriate for detecting subtle lesions as image resolution 492 
deteriorates with increasing depth and presence of subcutaneous or abdominal fat. 493 
A recent paper comparing computed tomography and ultrasonography 494 
demonstrated that significantly more clinically relevant lesions were identified 495 
using CT in patients over 25 kg.1 Computed tomography could therefore be 496 
considered as an alternative to ultrasound for a noninvasive evaluation of the 497 
gastrointestinal tract, however the intestinal wall layering displayed on CT 498 
evaluation is inferior compared to that displayed on US examination and also likely 499 
different features of the gastrointestinal wall are seen on CT examination, such as 500 
perfusion. 501 
Intestinal obstruction is major differential for veterinary patients presenting with 502 
vomiting as the primary clinical sign. Intestinal or gastric mucosal surface 503 
enhancement provides a clear distinction between wall and intraluminal contents, 504 
which may have similar attenuation values pre- contrast administration. This may 505 
enable identification of intraluminal partial/complete obstructions with a higher 506 
degree of confidence. Mural or extramural causes of intestinal obstruction may 507 
therefore be delineated without inference from intestinal gas or adjacent abdominal 508 
structures. However, further research is required to evaluate the sensitivity and 509 
specificity of dual phase contrast-enhanced CT for detecting intestinal obstruction. 510 
Specific CT features of acute and chronic inflammatory conditions in dogs and cats 511 
such as enteritis and inflammatory bowel disease have not yet been reported. There 512 
is a single case report of the CT appearance of a granulomatous lesion associated 513 
with inflammatory bowel disease in a Yorkshire terrier.19 These granulomatous type 514 
lesions are commonly seen in Crohn’s patients, which is a major type of 515 
inflammatory bowel disease (IBD) in the human population. The more common 516 
histological presentation of canine inflammatory bowel disease is 517 
lymphoplasmacytic enteritis.20 In full thickness intestinal biopsy samples, the main 518 
features of canine inflammatory bowel disease include cellular infiltration of the 519 
mucosa, focal, or transmural lymphangiectasia, and blunting of the villi.21 All of 520 
these changes are subtle and unlikely to be detected macroscopically regardless of 521 
which imaging modality is used. Measurement of intestinal wall thickness is not a 522 
useful indicator of intestinal pathology in cases of inflammatory bowel disease.22 A 523 
previous study has demonstrated that there is partial agreement between previously 524 
reported sonographic reference ranges and CT wall measurements.8 525 
One of the reported disadvantages of CT is that it does not allow for identification 526 
of distinct gastrointestinal wall layering as seen with ultrasonography. The cur- rent 527 
study demonstrated recognizable enhancement of the inner/luminal layer of the 528 
gastrointestinal tract segments using dual phase contrast-enhanced CT at optimal 529 
portal vein attenuation values. Subjectively, this enhancement involves one-third to 530 
half the wall thickness. The mucosal layer of the small intestine in particular has 531 
been demonstrated to contribute to up to two-thirds of the intestinal wall in both 532 
large and small breed dogs.23 Therefore, the authors assume that this enhancement 533 
correlates with part of, or the entire mucosal layer of the gastrointestinal wall. 534 
A large population of dogs with inflammatory or neo- plastic intestinal lesions was 535 
previously compared using ultrasound.24 A multivariate analysis of the ultrasound 536 
findings in these dogs identified loss of intestinal wall layering alone to be an 537 
excellent predictive factor in differentiating neoplastic from nonspecific 538 
enteropathy. In the human literature, different CT enhancement patterns have been 539 
associated with various types of intestinal neoplasia; however, there remains 540 
considerable overlap between benign and malignant conditions.25 Excluding 541 
sporadic case reports, very little information is available on the CT appearance of 542 
gastrointestinal masses in veterinary patients. 543 
There are a number of limitations for the current study. First, although the timing of 544 
image acquisition postcontrast was fixed at 30 s from the beginning of injection, the 545 
bolus infusion rates were variable between patients. The pilot study endeavored to 546 
standardize the stage of contrast enhancement by selecting cases with similar 547 
attenuation values in the portal vein. This may have introduced a se- lection bias in 548 
the cases used for the conspicuity analyses. The second limitation of this study was 549 
that histologic confirmation of normal gastrointestinal wall status was not obtained. 550 
It is therefore possible that animals with subclinical gastrointestinal wall disease 551 
could have been included. In this selection of clinical patients without 552 
gastrointestinal disease, obtaining full thickness biopsies to correlate the degree of 553 
mucosal surface enhancement with the histologic location and absence of disease 554 
would neither be ethical, as this is not a benign procedure, nor was there a clinical 555 
indication. Obtaining partial thickness biopsies, although arguably safer, would also 556 
not be without risk and was also not clinically indicated.26 557 
In conclusion, findings of the current study indicated that, for a complete evaluation 558 
of the gastrointestinal tract, dual phase contrast-enhanced CT offers advantages over 559 
standard postcontrast CT. An early postcontrast examination is recommended to 560 
evaluate small and large intestine. Specific portal vein values of 43–150 HU were 561 
correlated with good mucosal surface enhancement. Bolus tracking techniques or 562 
time attenuation curves may be used to achieve these portal vein attenuations. When 563 
using bolus-tracking techniques the time taken for the scan to begin must be taken 564 
into account. The timing of peak gastric body and pyloric antral mucosal surface 565 
enhancement has not been specifically identified. However, a late postcontrast 566 
examination (>60 s postcontrast) was found to be most useful when evaluating the 567 
gastric wall. In addition, the introduction of air into the gastric lumen may aid 568 
evaluation of the gastric wall. Further research is needed to define a repeatable 569 
protocol for optimizing gastrointestinal tract mucosal surface enhancement. Further 570 
studies are also needed to determine whether any change in the presumed normal 571 
enhancement patterns of gastrointestinal wall segments as described in this study 572 
occurs with diffuse gastrointestinal disease such as inflammatory bowel disease or 573 
infiltrative neoplasia such as lymphoma. Additionally, research is needed to 574 
evaluate the accuracy, sensitivity, and specificity of dual phase contrast- enhanced 575 
CT for detecting other common gastrointestinal diseases such as gastrointestinal 576 
ulceration and mechanical obstruction. 577 
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